COMPASSIONATE USE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH CROHN?S DISEASE WHO HAVE FAILED PREVIOUS TNF INHIBITOR THERAPIES

(1) University Hospital Leuven, Dept. of Gastroenterology, Leuven, Belgium

(2) Private Practice, Hamburg, Germany

(3) University of Leiden, Leiden, Netherlands

(4) St. Paul´s Hospital, Vancouver, Canada

(5) Hôpital Claude Huriez, Lille, France

(6) UCB, Braine l´Alleud, Belgium



This item was part of the Inflammatory Bowel Disease II session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A297